Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
94.610,59
-0,54%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alpha Tau Medical Ltd (DRTS) Alpha Tau Medical Ltd (DRTS) Notizie

DRTS

Alpha Tau Medical (DRTS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRTS
DataOraFonteTitoloSimboloCompagnia
18/12/202414:30GlobeNewswire Inc.Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update DayNASDAQ:DRTSAlpha Tau Medical Ltd
17/12/202415:00GlobeNewswire Inc.Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as AdvisorNASDAQ:DRTSAlpha Tau Medical Ltd
11/12/202414:30GlobeNewswire Inc.Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
06/12/202414:30GlobeNewswire Inc.Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors SymposiumNASDAQ:DRTSAlpha Tau Medical Ltd
19/11/202422:00GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
13/11/202414:30GlobeNewswire Inc.Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
21/10/202414:30GlobeNewswire Inc.Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeNASDAQ:DRTSAlpha Tau Medical Ltd
10/10/202414:30GlobeNewswire Inc.Alpha Tau Treats First Patient with Recurrent Lung CancerNASDAQ:DRTSAlpha Tau Medical Ltd
20/09/202414:30GlobeNewswire Inc.Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCNASDAQ:DRTSAlpha Tau Medical Ltd
22/08/202414:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
22/08/202414:30GlobeNewswire Inc.Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConNASDAQ:DRTSAlpha Tau Medical Ltd
14/08/202422:02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
25/06/202414:30GlobeNewswire Inc.Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersNASDAQ:DRTSAlpha Tau Medical Ltd
21/05/202414:45GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
20/05/202422:01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
13/05/202414:30GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSAlpha Tau Medical Ltd
06/05/202414:30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSAlpha Tau Medical Ltd
01/05/202414:30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
25/03/202413:50GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422:01GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
26/02/202414:30GlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
20/12/202315:15GlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
18/12/202317:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
29/11/202314:30GlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
28/11/202314:30GlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSAlpha Tau Medical Ltd
20/11/202314:30GlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSAlpha Tau Medical Ltd
16/11/202322:30GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
30/10/202313:30GlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSAlpha Tau Medical Ltd
24/10/202315:00GlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSAlpha Tau Medical Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRTS

La tua Cronologia

BOV
GRUL11
Icatu Vanguarda Gru Logi...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network